Gamma heavy-chain disease: Defining the spectrum of associated lymphoproliferative disorders through analysis of 13 cases

American Journal of Surgical Pathology

Volumn 36, Issue 4, 2012, Pages 534-543

  Bieliauskas, Shannon ^a   Tubbs, Raymond R ^a   Bacon, Chris M ^b,c   Eshoa, Camellia ^d   Foucar, Kathryn ^f   Gibson, Sarah E ^g   Kroft, Steven H ^e   Sohani, Aliyah R ^h   Swerdlow, Steven H ^g   Cook, James R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^d Medical College of Wisconsin   (United States)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

^f UNIVERSITY OF NEW MEXICO   (United States)

^g UNIVERSITY OF PITTSBURGH   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

gamma heavy chain disease; lymphoplasmacytic lymphoma; plasmacytic differentiation; small B cell lymphoma

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; B CELL LYMPHOMA; BLOOD; CELL CLONE; CHROMOSOME ANALYSIS; CLINICAL TRIAL; COMORBIDITY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HEAVY CHAIN DISEASE; HUMAN; IMMUNOPHENOTYPING; LYMPHOCYTE; LYMPHOID TISSUE; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PLASMA CELL; SEX DIFFERENCE; UNITED KINGDOM; UNITED STATES; WALDENSTROEM MACROGLOBULINEMIA;

ADULT; AGED; AUTOIMMUNE DISEASES; CLONE CELLS; COMORBIDITY; CYTOGENETIC ANALYSIS; FEMALE; GREAT BRITAIN; HEAVY CHAIN DISEASE; HUMANS; IMMUNOGLOBULIN GAMMA-CHAINS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOCYTES; LYMPHOID TISSUE; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; PLASMA CELLS; SEX FACTORS; TUMOR MARKERS, BIOLOGICAL; UNITED STATES; WALDENSTROM MACROGLOBULINEMIA;

EID: 84859099220     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318240590a     Document Type: Article

References (35)

1. Al-Saleem T, Al-Mondhiry H. Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms. Blood. 2005;105:2274-2280.
2. Amakawa R, Ohno H, Fukuhara S. t(9;14)(p13;q32) involving the PAX-5 gene: a unique subtype of 14q32 translocation in B cell non- Hodgkin's lymphoma. Int J Hematol. 1999;69:65-69.
3. Andriko JA, Swerdlow SH, Aguilera NI, et al. Is lymphoplasmacytic lymphoma/immunocytoma a distinct entity? A clinicopathologic study of 20 cases. Am J Surg Pathol. 2001;25:742-751.
4. Cogne M, Bakhshi A, Korsmeyer SJ, et al. Gene mutations and alternate RNA splicing result in truncated Ig L chains in human gamma H chain disease. J Immunol. 1988;141:1738-1744.
5. Cook JR, Aguilera NI, Reshmi-Skarja S, et al. Lack of PAX5 rearrangements in lymphoplasmacytic lymphomas: reassessing the reported association with t(9;14). Hum Pathol. 2004;35:447-454.
6. Corcos D, Osborn MJ, Matheson LS. B-cell receptors and heavy chain diseases: guilty by association? Blood. 2011;117:6991-6998.
7. Evans PAS, Pott C, PJTA Groenen, et al. Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia. 2007;21:207-214.
8. Fermand JP, Brouet JC. Heavy-chain diseases. Hematol/Oncol Clin N Am. 1999;13:1281-1294.
9. Fermand JP, Brouet JC, Danon F, et al. Gamma heavy chain "disease": heterogeneity of the clinicopathologic features. Report of 16 cases and review of the literature. Medicine. 1989;68:321-335.
10. Franklin EC, Lowenstein J, Bigelow B, et al. Heavy chain disease- a new disorder of serum gamma-globulins : report of the first case. Am J Med. 1964;37:332-350.
11. George TI, Wrede JE, Bangs CD, et al. Low-grade B-cell lymphomas with plasmacytic differentiation lack PAX5 gene rearrangements. J Mol Diagn . 2005;7:346-351.
12. Harris NL, Isaacson PG, Grogan TM, et al. Heavy chain diseases. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2008:196-199.
13. Hauke G, Schiltz E, Bross KJ, et al. Unusual sequence of immunoglobulin L-chain rearrangements in a gamma heavy chain disease patient. Scand J Immunol. 1992;36:463-468.
14. Husby G. Is there a pathogenic link between gamma heavy chain disease and chronic arthritis? Curr Opin Rheumatol. 2000;12:65-70.
15. Husby G, Blichfeldt P, Brinch L, et al. Chronic arthritis and gamma heavy chain disease: coincidence or pathogenic link? Scand J Rheumatol. 1998;27:257-264.
16. Iida S, Rao PH, Nallasivam P, et al. The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene. Blood. 1996;88:4110-4117.
17. Kyle RA, Greipp PR, Banks PM. The diverse picture of gamma heavy-chain disease. Report of seven cases and review of literature. Mayo Clin Proc. 1981;56:439-451.
18. Lee MT, Parwani A, Humphrey R, et al. Gamma heavy chain disease in a patient with diabetes and chronic renal insufficiency: diagnostic assessment of the heavy chain fragment. J Clin Lab Anal. 2008;22:146-150.
19. Lin P, Molina TJ, Cook JR, et al. Lymphoplasmacytic lymphoma and other non-marginal zone lymphomas with plasmacytic differentiation. Am J Clin Pathol. 2011;136:195-210.
20. Lopez-Anglada L, Puig N, Diez-Campelo M, et al. Monoclonal free light chains can be found in heavy chain diseases. Ann Clin Biochem. 2010;47:570-572.
21. Molina TJ, Lin P, Swerdlow SH, et al. Marginal zone lymphomas with plasmacytic differentiation and related disorders. Am J Clin Pathol. 2011;136:211-225.
22. Morita K, Kawamoto H, Takada H, et al. Unusual gamma heavy chain disease protein in a patient with splenic marginal-zone lymphoma. Ann Clin Biochem. 2006;43:161-164.
23. Munshi NC, Digumarthy S, Rahemtullah A. Case records of the Massachusetts General Hospital. Case 13-2008. A 46-year-old man with rheumatoid arthritis and lymphadenopathy. N Engl J Med. 2008;358:1838-1848.
24. Ruiz A, Reischl U, Swerdlow SH, et al. Extranodal marginal zone B-cell lymphomas of the ocular adnexa: multiparameter analysis of 34 cases including interphase molecular cytogenetics and PCR for Chlamydia psittaci. Am J Surg Pathol. 2007;31:792-802.
25. Salem PA, Estephan FF. Immunoproliferative small intestinal disease: current concepts. Cancer J. 2005;11:374-382.
26. Sargent RL, Cook JR, Aguilera NI, et al. Fluorescence immunophenotypic and interphase cytogenetic characterization of nodal lymphoplasmacytic lymphoma. Am J Surg Pathol. 2008;32: 1643-1653.
27. Swerdlow SH, Berger F, Pileri SA, et al. Lymphoplasmacytic lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2008:194-195.
28. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2008.
29. Teng MH, Rosen S, Gorny MK, et al. Gamma heavy chain disease in man: independent structural abnormalities and reduced transcription of a functionally rearranged lambda L-chain gene result in the absence of L-chains. Blood Cells Mol Dis. 2000;26:177-185.
30. van Dongen JJM, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17:2257-2317.
31. Wahner-Roedler DL, Kyle RA. Heavy chain diseases. Best Pract Res. 2005;18:729-746.
32. Wahner-Roedler DL, Witzig TE, Loehrer LL, et al. Gamma-heavy chain disease: review of 23 cases. Medicine. 2003;82:236-250.
33. Wester SM, Banks PM, Li CY. The histopathology of gamma heavy-chain disease. Am J Clin Pathol. 1982;78:427-436.
34. Witzig TE, Wahner-Roedler DL. Heavy chain disease. Curr Treat Options Oncol. 2002;3:247-254.
35. Wongchaowart NT, Kim B, Hsi ED, et al. t(14;18)(q32;q21) involving IGH and MALT1 is uncommon in cutaneous MALT lymphomas and primary cutaneous diffuse large B-cell lymphomas. J Cutan Pathol. 2006;33:286-292.